nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Stinging—Calcium Acetate—osteoporosis	0.0401	0.0533	CcSEcCtD
Levocabastine—Ocular hyperaemia—Zoledronate—osteoporosis	0.027	0.0359	CcSEcCtD
Levocabastine—Ocular hyperaemia—Estradiol—osteoporosis	0.0208	0.0277	CcSEcCtD
Levocabastine—Eyelid oedema—Estradiol—osteoporosis	0.0193	0.0257	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—MGLL—osteoporosis	0.0162	0.0653	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.0145	0.0584	CbGpPWpGaD
Levocabastine—Visual disturbance—Estropipate—osteoporosis	0.0141	0.0188	CcSEcCtD
Levocabastine—Visual disturbance—Ethinyl Estradiol—osteoporosis	0.0114	0.0152	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CALCR—osteoporosis	0.0103	0.0414	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—PTH1R—osteoporosis	0.0103	0.0414	CbGpPWpGaD
Levocabastine—Eye pain—Zoledronate—osteoporosis	0.0102	0.0135	CcSEcCtD
Levocabastine—Pain—Calcium Acetate—osteoporosis	0.0099	0.0132	CcSEcCtD
Levocabastine—Visual disturbance—Conjugated Estrogens—osteoporosis	0.00933	0.0124	CcSEcCtD
Levocabastine—Erythema—Etidronic acid—osteoporosis	0.00932	0.0124	CcSEcCtD
Levocabastine—Pharyngitis—Estropipate—osteoporosis	0.00919	0.0122	CcSEcCtD
Levocabastine—Visual impairment—Estropipate—osteoporosis	0.00892	0.0119	CcSEcCtD
Levocabastine—Pharyngitis—Raloxifene—osteoporosis	0.0089	0.0118	CcSEcCtD
Levocabastine—Pharyngitis—Ibandronate—osteoporosis	0.00881	0.0117	CcSEcCtD
Levocabastine—Pain—Ergocalciferol—osteoporosis	0.00875	0.0116	CcSEcCtD
Levocabastine—Asthenia—Calcium Acetate—osteoporosis	0.00831	0.0111	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00808	0.0325	CbGpPWpGaD
Levocabastine—Erythema—Estropipate—osteoporosis	0.00806	0.0107	CcSEcCtD
Levocabastine—Erythema—Alendronate—osteoporosis	0.00794	0.0106	CcSEcCtD
Levocabastine—Erythema—Ibandronate—osteoporosis	0.00773	0.0103	CcSEcCtD
Levocabastine—Erythema—Calcitriol—osteoporosis	0.00757	0.0101	CcSEcCtD
Levocabastine—Visual disturbance—Estradiol—osteoporosis	0.00747	0.00994	CcSEcCtD
Levocabastine—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.00745	0.00991	CcSEcCtD
Levocabastine—Asthenia—Ergocalciferol—osteoporosis	0.00734	0.00977	CcSEcCtD
Levocabastine—Pharyngitis—Risedronate—osteoporosis	0.00726	0.00966	CcSEcCtD
Levocabastine—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00723	0.00962	CcSEcCtD
Levocabastine—Cough—Estropipate—osteoporosis	0.00703	0.00936	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00693	0.0279	CbGpPWpGaD
Levocabastine—Nausea—Calcium Acetate—osteoporosis	0.00688	0.00915	CcSEcCtD
Levocabastine—Cough—Raloxifene—osteoporosis	0.00681	0.00907	CcSEcCtD
Levocabastine—Dry mouth—Ibandronate—osteoporosis	0.00643	0.00856	CcSEcCtD
Levocabastine—Dry mouth—Calcitriol—osteoporosis	0.0063	0.00838	CcSEcCtD
Levocabastine—Nausea—Ergocalciferol—osteoporosis	0.00608	0.00809	CcSEcCtD
Levocabastine—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00607	0.00808	CcSEcCtD
Levocabastine—Erythema—Pamidronate—osteoporosis	0.00605	0.00806	CcSEcCtD
Levocabastine—Visual impairment—Conjugated Estrogens—osteoporosis	0.0059	0.00785	CcSEcCtD
Levocabastine—Somnolence—Estropipate—osteoporosis	0.00585	0.00778	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PTH1R—osteoporosis	0.00582	0.0234	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CALCR—osteoporosis	0.00582	0.0234	CbGpPWpGaD
Levocabastine—Cough—Ethinyl Estradiol—osteoporosis	0.0057	0.00759	CcSEcCtD
Levocabastine—Fatigue—Estropipate—osteoporosis	0.00567	0.00755	CcSEcCtD
Levocabastine—Pain—Estropipate—osteoporosis	0.00562	0.00749	CcSEcCtD
Levocabastine—Cough—Risedronate—osteoporosis	0.00556	0.0074	CcSEcCtD
Levocabastine—Pain—Alendronate—osteoporosis	0.00554	0.00737	CcSEcCtD
Levocabastine—Erythema—Zoledronate—osteoporosis	0.00553	0.00736	CcSEcCtD
Levocabastine—Somnolence—Calcitriol—osteoporosis	0.00549	0.0073	CcSEcCtD
Levocabastine—Pain—Raloxifene—osteoporosis	0.00545	0.00725	CcSEcCtD
Levocabastine—Fatigue—Ibandronate—osteoporosis	0.00544	0.00724	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—PTH—osteoporosis	0.00541	0.0218	CbGpPWpGaD
Levocabastine—Pain—Ibandronate—osteoporosis	0.00539	0.00718	CcSEcCtD
Levocabastine—Erythema—Conjugated Estrogens—osteoporosis	0.00533	0.00709	CcSEcCtD
Levocabastine—Dry mouth—Risedronate—osteoporosis	0.0053	0.00706	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CALCR—osteoporosis	0.00529	0.0213	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PTH1R—osteoporosis	0.00529	0.0213	CbGpPWpGaD
Levocabastine—Cough—Pamidronate—osteoporosis	0.00528	0.00703	CcSEcCtD
Levocabastine—Pain—Calcitriol—osteoporosis	0.00528	0.00703	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CNR2—osteoporosis	0.00527	0.0212	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—WNT1—osteoporosis	0.00496	0.0199	CbGpPWpGaD
Levocabastine—Pharyngitis—Estradiol—osteoporosis	0.00486	0.00647	CcSEcCtD
Levocabastine—Cough—Zoledronate—osteoporosis	0.00483	0.00642	CcSEcCtD
Levocabastine—Rash—Etidronic acid—osteoporosis	0.00479	0.00638	CcSEcCtD
Levocabastine—Dermatitis—Etidronic acid—osteoporosis	0.00479	0.00637	CcSEcCtD
Levocabastine—Headache—Etidronic acid—osteoporosis	0.00476	0.00634	CcSEcCtD
Levocabastine—Asthenia—Estropipate—osteoporosis	0.00472	0.00628	CcSEcCtD
Levocabastine—Visual impairment—Estradiol—osteoporosis	0.00472	0.00628	CcSEcCtD
Levocabastine—Asthenia—Alendronate—osteoporosis	0.00465	0.00619	CcSEcCtD
Levocabastine—Cough—Conjugated Estrogens—osteoporosis	0.00465	0.00618	CcSEcCtD
Levocabastine—Dyspnoea—Risedronate—osteoporosis	0.00463	0.00617	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—MGLL—osteoporosis	0.00463	0.0186	CbGpPWpGaD
Levocabastine—Dry mouth—Zoledronate—osteoporosis	0.0046	0.00613	CcSEcCtD
Levocabastine—Fatigue—Ethinyl Estradiol—osteoporosis	0.0046	0.00612	CcSEcCtD
Levocabastine—Asthenia—Ibandronate—osteoporosis	0.00453	0.00602	CcSEcCtD
Levocabastine—Nausea—Etidronic acid—osteoporosis	0.00452	0.00601	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—PTHLH—osteoporosis	0.00448	0.018	CbGpPWpGaD
Levocabastine—Fatigue—Risedronate—osteoporosis	0.00448	0.00596	CcSEcCtD
Levocabastine—Pain—Risedronate—osteoporosis	0.00445	0.00592	CcSEcCtD
Levocabastine—Asthenia—Calcitriol—osteoporosis	0.00443	0.0059	CcSEcCtD
Levocabastine—Dyspnoea—Pamidronate—osteoporosis	0.00441	0.00586	CcSEcCtD
Levocabastine—Somnolence—Pamidronate—osteoporosis	0.00439	0.00585	CcSEcCtD
Levocabastine—Erythema—Estradiol—osteoporosis	0.00426	0.00567	CcSEcCtD
Levocabastine—Fatigue—Pamidronate—osteoporosis	0.00426	0.00567	CcSEcCtD
Levocabastine—Pain—Pamidronate—osteoporosis	0.00423	0.00562	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—MGLL—osteoporosis	0.0042	0.0169	CbGpPWpGaD
Levocabastine—Rash—Estropipate—osteoporosis	0.00415	0.00552	CcSEcCtD
Levocabastine—Dermatitis—Estropipate—osteoporosis	0.00414	0.00551	CcSEcCtD
Levocabastine—Headache—Estropipate—osteoporosis	0.00412	0.00548	CcSEcCtD
Levocabastine—Rash—Alendronate—osteoporosis	0.00408	0.00544	CcSEcCtD
Levocabastine—Dermatitis—Alendronate—osteoporosis	0.00408	0.00543	CcSEcCtD
Levocabastine—Headache—Alendronate—osteoporosis	0.00406	0.0054	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—POMC—osteoporosis	0.00404	0.0163	CbGpPWpGaD
Levocabastine—Dyspnoea—Zoledronate—osteoporosis	0.00402	0.00536	CcSEcCtD
Levocabastine—Rash—Raloxifene—osteoporosis	0.00402	0.00535	CcSEcCtD
Levocabastine—Dermatitis—Raloxifene—osteoporosis	0.00401	0.00534	CcSEcCtD
Levocabastine—Somnolence—Zoledronate—osteoporosis	0.00401	0.00534	CcSEcCtD
Levocabastine—Headache—Raloxifene—osteoporosis	0.00399	0.00531	CcSEcCtD
Levocabastine—Rash—Ibandronate—osteoporosis	0.00398	0.00529	CcSEcCtD
Levocabastine—Dermatitis—Ibandronate—osteoporosis	0.00397	0.00529	CcSEcCtD
Levocabastine—Headache—Ibandronate—osteoporosis	0.00395	0.00526	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CALCA—osteoporosis	0.00395	0.0159	CbGpPWpGaD
Levocabastine—Nausea—Estropipate—osteoporosis	0.00391	0.0052	CcSEcCtD
Levocabastine—Rash—Calcitriol—osteoporosis	0.00389	0.00518	CcSEcCtD
Levocabastine—Fatigue—Zoledronate—osteoporosis	0.00389	0.00518	CcSEcCtD
Levocabastine—Dermatitis—Calcitriol—osteoporosis	0.00389	0.00518	CcSEcCtD
Levocabastine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00387	0.00516	CcSEcCtD
Levocabastine—Headache—Calcitriol—osteoporosis	0.00387	0.00515	CcSEcCtD
Levocabastine—Somnolence—Conjugated Estrogens—osteoporosis	0.00386	0.00514	CcSEcCtD
Levocabastine—Pain—Zoledronate—osteoporosis	0.00386	0.00514	CcSEcCtD
Levocabastine—Nausea—Alendronate—osteoporosis	0.00385	0.00512	CcSEcCtD
Levocabastine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00383	0.00509	CcSEcCtD
Levocabastine—Nausea—Raloxifene—osteoporosis	0.00378	0.00504	CcSEcCtD
Levocabastine—Fatigue—Conjugated Estrogens—osteoporosis	0.00375	0.00499	CcSEcCtD
Levocabastine—Nausea—Ibandronate—osteoporosis	0.00375	0.00499	CcSEcCtD
Levocabastine—Asthenia—Risedronate—osteoporosis	0.00373	0.00496	CcSEcCtD
Levocabastine—Cough—Estradiol—osteoporosis	0.00372	0.00495	CcSEcCtD
Levocabastine—Pain—Conjugated Estrogens—osteoporosis	0.00372	0.00495	CcSEcCtD
Levocabastine—Nausea—Calcitriol—osteoporosis	0.00367	0.00488	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00357	0.0144	CbGpPWpGaD
Levocabastine—Dry mouth—Estradiol—osteoporosis	0.00355	0.00472	CcSEcCtD
Levocabastine—Asthenia—Pamidronate—osteoporosis	0.00355	0.00472	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—SOST—osteoporosis	0.00345	0.0139	CbGpPWpGaD
Levocabastine—Rash—Ethinyl Estradiol—osteoporosis	0.00336	0.00447	CcSEcCtD
Levocabastine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00336	0.00447	CcSEcCtD
Levocabastine—Headache—Ethinyl Estradiol—osteoporosis	0.00334	0.00444	CcSEcCtD
Levocabastine—Rash—Risedronate—osteoporosis	0.00328	0.00436	CcSEcCtD
Levocabastine—Dermatitis—Risedronate—osteoporosis	0.00327	0.00436	CcSEcCtD
Levocabastine—Headache—Risedronate—osteoporosis	0.00326	0.00433	CcSEcCtD
Levocabastine—Asthenia—Zoledronate—osteoporosis	0.00324	0.00431	CcSEcCtD
Levocabastine—Nausea—Ethinyl Estradiol—osteoporosis	0.00317	0.00421	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—PTH1R—osteoporosis	0.00312	0.0126	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CALCR—osteoporosis	0.00312	0.0126	CbGpPWpGaD
Levocabastine—Asthenia—Conjugated Estrogens—osteoporosis	0.00312	0.00415	CcSEcCtD
Levocabastine—Rash—Pamidronate—osteoporosis	0.00312	0.00415	CcSEcCtD
Levocabastine—Dermatitis—Pamidronate—osteoporosis	0.00311	0.00414	CcSEcCtD
Levocabastine—Dyspnoea—Estradiol—osteoporosis	0.0031	0.00413	CcSEcCtD
Levocabastine—Headache—Pamidronate—osteoporosis	0.0031	0.00412	CcSEcCtD
Levocabastine—Somnolence—Estradiol—osteoporosis	0.00309	0.00412	CcSEcCtD
Levocabastine—Nausea—Risedronate—osteoporosis	0.00309	0.00411	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PTH—osteoporosis	0.00306	0.0123	CbGpPWpGaD
Levocabastine—Fatigue—Estradiol—osteoporosis	0.003	0.00399	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CNR2—osteoporosis	0.00298	0.012	CbGpPWpGaD
Levocabastine—Pain—Estradiol—osteoporosis	0.00297	0.00396	CcSEcCtD
Levocabastine—Nausea—Pamidronate—osteoporosis	0.00294	0.00391	CcSEcCtD
Levocabastine—Rash—Zoledronate—osteoporosis	0.00285	0.00379	CcSEcCtD
Levocabastine—Dermatitis—Zoledronate—osteoporosis	0.00284	0.00378	CcSEcCtD
Levocabastine—Headache—Zoledronate—osteoporosis	0.00283	0.00376	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—PTH—osteoporosis	0.00278	0.0112	CbGpPWpGaD
Levocabastine—Rash—Conjugated Estrogens—osteoporosis	0.00274	0.00365	CcSEcCtD
Levocabastine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00274	0.00364	CcSEcCtD
Levocabastine—Headache—Conjugated Estrogens—osteoporosis	0.00272	0.00362	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00271	0.0109	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CNR2—osteoporosis	0.00271	0.0109	CbGpPWpGaD
Levocabastine—Nausea—Zoledronate—osteoporosis	0.00268	0.00357	CcSEcCtD
Levocabastine—Nausea—Conjugated Estrogens—osteoporosis	0.00258	0.00344	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—WNT1—osteoporosis	0.00254	0.0102	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PTHLH—osteoporosis	0.00253	0.0102	CbGpPWpGaD
Levocabastine—Asthenia—Estradiol—osteoporosis	0.0025	0.00332	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—MGLL—osteoporosis	0.00248	0.00998	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—MGLL—osteoporosis	0.00246	0.0099	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LRP5—osteoporosis	0.00242	0.00974	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LRP6—osteoporosis	0.00232	0.00932	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PTHLH—osteoporosis	0.0023	0.00926	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CALCA—osteoporosis	0.00223	0.00898	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.0022	0.00886	CbGpPWpGaD
Levocabastine—Rash—Estradiol—osteoporosis	0.00219	0.00292	CcSEcCtD
Levocabastine—Dermatitis—Estradiol—osteoporosis	0.00219	0.00292	CcSEcCtD
Levocabastine—Headache—Estradiol—osteoporosis	0.00218	0.0029	CcSEcCtD
Levocabastine—Nausea—Estradiol—osteoporosis	0.00207	0.00275	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—POMC—osteoporosis	0.00207	0.00831	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CALCA—osteoporosis	0.00203	0.00815	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—IRS2—osteoporosis	0.002	0.00803	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TLN1—osteoporosis	0.00196	0.00787	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—IRS1—osteoporosis	0.00174	0.00701	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—P4HB—osteoporosis	0.00169	0.00679	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTH—osteoporosis	0.00164	0.0066	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—RAP1A—osteoporosis	0.00161	0.00649	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CNR2—osteoporosis	0.0016	0.00643	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00159	0.0064	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—ADCY5—osteoporosis	0.00159	0.00638	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NFATC1—osteoporosis	0.00157	0.00633	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CALCR—osteoporosis	0.00156	0.00629	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTH1R—osteoporosis	0.00156	0.00629	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—DKK1—osteoporosis	0.00156	0.00628	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—WNT1—osteoporosis	0.0015	0.00605	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGA—osteoporosis	0.00146	0.00588	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—ADCY5—osteoporosis	0.00144	0.0058	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTHLH—osteoporosis	0.00136	0.00547	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BMP2—osteoporosis	0.00136	0.00547	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGB—osteoporosis	0.00133	0.00535	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PSMA2—osteoporosis	0.00128	0.00517	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PSMA5—osteoporosis	0.00128	0.00517	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00123	0.00493	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CALCA—osteoporosis	0.0012	0.00482	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—POMC—osteoporosis	0.00117	0.0047	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KL—osteoporosis	0.00109	0.00437	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—POMC—osteoporosis	0.00106	0.00426	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00105	0.00423	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6R—osteoporosis	0.00103	0.00416	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CALCR—osteoporosis	0.000883	0.00355	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTH1R—osteoporosis	0.000883	0.00355	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ADCY5—osteoporosis	0.000851	0.00343	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SPP1—osteoporosis	0.000824	0.00331	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTH—osteoporosis	0.000821	0.0033	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CALCR—osteoporosis	0.000802	0.00323	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTH1R—osteoporosis	0.000802	0.00323	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CNR2—osteoporosis	0.0008	0.00322	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—WNT1—osteoporosis	0.000752	0.00303	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IRS2—osteoporosis	0.000745	0.003	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LEP—osteoporosis	0.000729	0.00293	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—MGLL—osteoporosis	0.000702	0.00282	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ESR1—osteoporosis	0.000696	0.0028	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTHLH—osteoporosis	0.00068	0.00274	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IRS1—osteoporosis	0.00065	0.00262	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MGLL—osteoporosis	0.000637	0.00256	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—POMC—osteoporosis	0.000626	0.00252	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6R—osteoporosis	0.000611	0.00246	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IGF1—osteoporosis	0.000602	0.00242	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CALCA—osteoporosis	0.000599	0.00241	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000542	0.00218	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SOST—osteoporosis	0.000524	0.00211	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CALCR—osteoporosis	0.000474	0.00191	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTH1R—osteoporosis	0.000474	0.00191	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTH—osteoporosis	0.000464	0.00187	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—osteoporosis	0.000461	0.00185	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CNR2—osteoporosis	0.000452	0.00182	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTH—osteoporosis	0.000421	0.00169	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000411	0.00166	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CNR2—osteoporosis	0.000411	0.00165	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—WNT1—osteoporosis	0.000386	0.00155	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	0.000384	0.00155	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MGLL—osteoporosis	0.000376	0.00151	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LRP5—osteoporosis	0.000367	0.00148	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—osteoporosis	0.000362	0.00146	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TGFB1—osteoporosis	0.000361	0.00145	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LRP6—osteoporosis	0.000351	0.00141	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTHLH—osteoporosis	0.000349	0.0014	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CALCA—osteoporosis	0.000338	0.00136	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—POMC—osteoporosis	0.000313	0.00126	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CALCA—osteoporosis	0.000307	0.00124	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TLN1—osteoporosis	0.000297	0.00119	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—osteoporosis	0.000272	0.00109	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—P4HB—osteoporosis	0.000256	0.00103	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTH—osteoporosis	0.000249	0.001	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RAP1A—osteoporosis	0.000245	0.000984	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CNR2—osteoporosis	0.000243	0.000976	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000241	0.000971	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	0.000241	0.000968	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NFATC1—osteoporosis	0.000239	0.00096	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DKK1—osteoporosis	0.000237	0.000952	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—WNT1—osteoporosis	0.000228	0.000917	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGA—osteoporosis	0.000222	0.000892	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	0.000219	0.000879	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTHLH—osteoporosis	0.000206	0.00083	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BMP2—osteoporosis	0.000206	0.00083	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGB—osteoporosis	0.000202	0.000812	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PSMA5—osteoporosis	0.000195	0.000784	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PSMA2—osteoporosis	0.000195	0.000784	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CALCA—osteoporosis	0.000182	0.00073	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—POMC—osteoporosis	0.000177	0.000712	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KL—osteoporosis	0.000165	0.000663	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—POMC—osteoporosis	0.000161	0.000647	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6R—osteoporosis	0.000157	0.000631	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ADCY5—osteoporosis	0.000129	0.00052	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SPP1—osteoporosis	0.000125	0.000503	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IRS2—osteoporosis	0.000113	0.000455	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LEP—osteoporosis	0.000111	0.000445	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ESR1—osteoporosis	0.000106	0.000425	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IRS1—osteoporosis	9.86e-05	0.000397	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—POMC—osteoporosis	9.5e-05	0.000382	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6R—osteoporosis	9.27e-05	0.000373	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IGF1—osteoporosis	9.14e-05	0.000368	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—osteoporosis	6.99e-05	0.000281	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—osteoporosis	5.49e-05	0.000221	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFB1—osteoporosis	5.48e-05	0.00022	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—osteoporosis	4.13e-05	0.000166	CbGpPWpGaD
